WGS Key Statistics, Chart & Performance
The current stock price of WGS is 91.44 USD. In the past month the price decreased by -16.75%. In the past year, price increased by 19.76%.
WGS Technical Analysis
WGS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to WGS. No worries on liquidiy or solvency for WGS as it has an excellent financial health rating, but there are worries on the profitability.
WGS Financial Highlights
Over the last trailing twelve months WGS reported a non-GAAP Earnings per Share(EPS) of 1.88. The EPS increased by 274.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.52% | ||
| ROA | 0.42% | ||
| ROE | 0.71% | ||
| Debt/Equity | 0.18 |
WGS Forecast & Estimates
13 analysts have analysed WGS and the average price target is 174.31 USD. This implies a price increase of 90.62% is expected in the next year compared to the current price of 91.44.
For the next year, analysts expect an EPS growth of 509.76% and a revenue growth 47.15% for WGS
WGS Ownership
WGS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.64 | 96.096B | ||
| CI | THE CIGNA GROUP | 9.43 | 75.826B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 97.51 | 23.754B | ||
| LH | LABCORP HOLDINGS INC | 16.09 | 23.585B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.91 | 22.843B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.532B | ||
| DVA | DAVITA INC | 10.91 | 9.548B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.24 | 7.095B | ||
| CHE | CHEMED CORP | 18.04 | 6.4B | ||
| RDNT | RADNET INC | 87.32 | 5.406B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About WGS
Company Profile
GeneDx Holdings Corp. operates as a health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,000 full-time employees. The company went IPO on 2020-09-04. The firm operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. The company operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. The company offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Company Info
GENEDX HOLDINGS CORP
333 Ludlow Street, North Tower, 6Th Floor
Stamford CONNECTICUT US
Employees: 1000
Phone: 18009279800
GENEDX HOLDINGS CORP / WGS FAQ
Can you describe the business of GENEDX HOLDINGS CORP?
GeneDx Holdings Corp. operates as a health intelligence company. The company is headquartered in Stamford, Connecticut and currently employs 1,000 full-time employees. The company went IPO on 2020-09-04. The firm operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. The company operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. The company offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
What is the current price of WGS stock?
The current stock price of WGS is 91.44 USD. The price decreased by -3.52% in the last trading session.
Does WGS stock pay dividends?
WGS does not pay a dividend.
How is the ChartMill rating for GENEDX HOLDINGS CORP?
WGS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What sector and industry does GENEDX HOLDINGS CORP belong to?
GENEDX HOLDINGS CORP (WGS) operates in the Health Care sector and the Health Care Providers & Services industry.
How is the valuation of GENEDX HOLDINGS CORP (WGS) based on its PE ratio?
The PE ratio for GENEDX HOLDINGS CORP (WGS) is 48.64. This is based on the reported non-GAAP earnings per share of 1.88 and the current share price of 91.44 USD.
Can you provide the number of employees for GENEDX HOLDINGS CORP?
GENEDX HOLDINGS CORP (WGS) currently has 1000 employees.